Sponsored by MC Services 10 Mar 2023Meet some of the biotechs attending Bio-Europe Spring 2023 As Bio-Europe Spring 2023 is set to take place from March 20 to March 22 in Basel, Switzerland, a budding… March 10, 2023 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 16 Feb 2023Newron reports ‘striking’ schizophrenia study results Newron Pharmaceuticals S.p.A. has announced what it says are ‘very exciting new results’ from the first 100 randomized patients who… February 16, 2023 - 5 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 6 Jan 2023Beyond Biotech podcast 28: Mainz Biomed, Newron Pharmaceuticals This week, we have two guests. We have conversations with Newron CEO, Stefan Weber, and Mainz Biomed CEO, Guido Bächler.… January 6, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 3 Jan 2023Newron announces interim results from treatment-resistant schizophrenia trial Newron Pharmaceuticals S.p.A. has announced what it says are “very compelling new results” from the first 100 enrolled patients to… January 3, 2023 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 8 May 2020Phase III Failure Sinks Drug for Rare Neurological Disorder The Italian biotech Newron is halting the development of the experimental drug sarizotan after it failed to meet efficacy endpoints… May 8, 2020 - 4 minutesmins - By Anita Chakraverty Share WhatsApp Twitter Linkedin Email
News and Trends 7 Nov 2017British Researchers Find Thought Police to Treat Neurological Disorders Cambridge University scientists have identified a chemical in the brain that blocks unwanted thoughts, offering a new avenue to treat neurological… November 7, 2017 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
Best in Biotech 10 Oct 2017Buongiorno Biotech! Top 4 Companies Making Milan Europe’s Next Biotech Hub Italy may not be the first country that comes to mind when you think of biotech, but the sun is… October 10, 2017 - 7 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 12 May 2017UPDATE: Italian Pharma receives €11M for Parkinson’s Drug Approval UPDATE (12/05/2017): Newron has received €11.3M as a milestone payment for the approval from its partner, Zambon, which has the… May 12, 2017 - 2 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
Interview 20 Apr 2017Newron’s Journey to Launch the First Parkinson’s Drug in 11 Years Philip talked to Stefan Weber, CEO of Newron Pharmaceuticals, in our first meetup in Munich last week. His company has… April 20, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Infographics 21 Feb 2017Infographic: The Biggest Biotech Company in Each European Country We had a look into European biotech and created a map with the biggest biotech companies in each country, according… February 21, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 11 Oct 2016World Mental Health Day: How is Biotech Helping the Cause? Biotech is one of the main forces driving the development of effective therapies to treat neurological and mental disorders. For World Mental… October 11, 2016 - 4 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 17 May 2016New Italian Drug is FDA approved for trials in Rare Neurological Disease Newron sees its Investigational New Drug application approved by the FDA. It can now begin clinical trials for Rett Syndrome patients -… May 17, 2016 - 2 minutesmins - By Denise Neves Gameiro Share WhatsApp Twitter Linkedin Email
News and Trends 16 Nov 2015Swissmedic Approves Zambon and Newron Therapy against Parkinson’s Italian Pharma Newron and its partner Zambon (from Milan) have been granted a license by Swissmedic (the regulatory agency in Switzerland)… November 16, 2015 - 2 minutesmins - By Julie Lellouche Share WhatsApp Twitter Linkedin Email
News and Trends 14 Jul 2015Newron’s ressurection story continues with a FDA Orphan Drug designation New success for Newron Pharmaceuticals. The FDA approved Orphan Drug designation to its new chemical entity Sarizotan, designed to treat… July 14, 2015 - 2 minutesmins - By Philip Hemme Share WhatsApp Twitter Linkedin Email
News and Trends 2 May 2015Newron raised new funds to continue the development of Neurological therapies Newron Pharmaceuticals, a public company focused on novel Central Nervous System (CNS) and pain therapies, announces that it has completed a… May 2, 2015 - 2 minutesmins - By Joachim Eeckhout Share WhatsApp Twitter Linkedin Email